De novo design and bioactivity prediction of mitotic kinesin Eg5 inhibitors using MPNN and LSTM-based transfer learning
Our latest academic publication in Computers in Biology and Medicine demonstrates the application of advanced AI techniques including Message Passing Neural Networks and Long Short-Term Memory models for drug discovery and bioactivity prediction.
Computers in Biology and Medicine